Clinical Trial

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-20; most recent amendment 2026-03-31.
Trial Details
NCT Number NCT07030400
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Comprehensive Cancer Network, AstraZeneca
Conditions Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL)
Enrollment 100 participants
Start Date 2025-07-17
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-01